文献速递免疫规划

GEM-PA纳米陷阱用于口蹄疫病毒纯化的开发

Development of GEM-PA-nanotrap for purification of foot-and-mouth disease virus.
PubMed 文献 · Vaccine · 2019-04-26

本研究开发了一种基于纳米抗体与肽聚糖结合蛋白锚偶联于GEM颗粒的亲和纯化方法GEM-PA-nanotrap,用于从细胞裂解液中纯化口蹄疫病毒。该方法病毒回收率超过99%,非病毒蛋白去除效率约98.3%,且对146S颗粒完整性和免疫原性几乎无影响。

要点

  • GEM-PA-nanotrap可从细胞裂解液中纯化口蹄疫病毒,回收率超过99%。
  • 该方法非病毒蛋白去除效率约98.3%。
  • 纯化过程对146S颗粒完整性和免疫原性几乎无影响。

核心结论

  • GEM-PA-nanotrap有望成为疫苗生产过程中口蹄疫病毒回收和纯化的有效方法。

研究设计与样本

  • 从非免疫文库中筛选针对口蹄疫病毒疫苗株O/MYA98/BY/2010 146S颗粒的纳米抗体Nb205,与肽聚糖结合蛋白锚PA融合,非共价偶联到GEM颗粒表面构建GEM-PA-nanotrap。
  • GEM颗粒由非活性、非转基因、食品级革兰阳性乳酸乳球菌制备。
  • 通过简单孵育和离心步骤从细胞裂解液中纯化口蹄疫病毒。

主要发现

  • 口蹄疫病毒回收率超过99%。
  • 非病毒蛋白去除效率约98.3%。
  • 纯化过程对146S颗粒完整性和免疫原性几乎无影响。

临床怎么用

  • 该方法可用于口蹄疫灭活疫苗生产过程中口蹄疫病毒的回收与纯化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vaccination is the primary preventative measure against outbreaks of foot-and-mouth disease (FMD). The efficacy of inactivated FMD vaccines is mainly determined by the integrity of foot-and-mouth disease virus (FMDV) particles (referred to as 146S particles), and impurities in the inactivated vaccines could result in side effects. In this study, we developed an effective affinity purification method for the purification of FMDV from cellular lysates, referred to as GEM-PA-nanotrap. To develop the GEM-PA-nanotrap, a nanobody (Nb205) against FMDV vaccine strain O/MYA98/BY/2010 146S particles was selected from a non-immunized library and fused to a peptidoglycan-binding protein anchor (PA). The PA-Nb205 fusion protein was non-covalently coupled to the surface of Gram-positive enhancer matrix (GEM) particles, which were prepared from the non-living, non-genetically modified, Gram-positive, food-grade Lactococcus lactis bacteria. The GEM-PA-nanotrap was used to purify FMDV from cellular lysates through a simple incubation and centrifugation step. The FMDV recovery rate was more than 99%, the efficiency of nonviral protein removal was about 98.3%, and the purification process had almost no effect on the integrity and immunogenicity of 146S particles. Therefore, the GEM-PA-nanotrap has potential as an effective method for the recovery and purification of FMDV during the vaccine manufacturing process.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Cheng H, Chen J, Cai Z, et al. Development of GEM-PA-nanotrap for purification of foot-and-mouth disease virus. Vaccine. 2019. PMID: 31036456. doi:10.1016/j.vaccine.2019.04.078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。